Today, the U.S. Food and Drug Administration (FDA) issued an immediately in effect guidance to help expand the availability of telethermographic systems used for body temperature measurements for triage use.
The advantage of telethermographic systems for initial temperature assessment for triage use is the potential use in high throughput areas (such as airports, businesses, warehouses, and factories) and in settings where other temperature assessment products may be in short supply.
This policy reflects the FDA’s commitment to ease burdens on health care providers and facilities as they face the COVID-19 public health emergency.
Read the Guidance
U.S. Food and Drug Administration